Search
Menu
Home
Sources
About
Contacts
Savolitinib
Savolitinib
is an
experimental
small molecule
inhibitor
of
c-Met
. It is being investigated for the
treatment of cancer
by
AstraZeneca
. It is
in phase
II
clinical trials
for
adenocarcinoma
,
non-small cell lung cancer
, and
renal cell carcinoma
.